KR102252763B1 - Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity - Google Patents
Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity Download PDFInfo
- Publication number
- KR102252763B1 KR102252763B1 KR1020190082195A KR20190082195A KR102252763B1 KR 102252763 B1 KR102252763 B1 KR 102252763B1 KR 1020190082195 A KR1020190082195 A KR 1020190082195A KR 20190082195 A KR20190082195 A KR 20190082195A KR 102252763 B1 KR102252763 B1 KR 102252763B1
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- ginseng extract
- reduced
- chromaticity
- kda
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 132
- 239000000284 extract Substances 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000012528 membrane Substances 0.000 claims abstract description 43
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 35
- 239000002537 cosmetic Substances 0.000 claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 claims abstract description 26
- 235000013305 food Nutrition 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims description 42
- 229930182494 ginsenoside Natural products 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000004475 Arginine Substances 0.000 claims description 14
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 14
- 229940089161 ginsenoside Drugs 0.000 claims description 12
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 19
- 239000004480 active ingredient Substances 0.000 abstract description 17
- 238000001914 filtration Methods 0.000 abstract description 11
- 240000004371 Panax ginseng Species 0.000 description 21
- 235000008434 ginseng Nutrition 0.000 description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 17
- 235000008504 concentrate Nutrition 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- -1 AFG Natural products 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000000344 soap Substances 0.000 description 7
- 229920001353 Dextrin Polymers 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 235000019425 dextrin Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000001766 physiological effect Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000002337 glycosamines Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 241001527087 Panax vietnamensis Species 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 1
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 240000003296 Petasites japonicus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000037333 procollagen synthesis Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 색도가 감소된 홍삼 추출물의 제조 방법에 관한 것으로, 홍삼 추출물을 소정의 분획 분자량을 가지는 한외여과막으로 여과함으로써, 색도가 감소되고, 유효성분은 강화된 홍삼 추출물을 얻을 수 있다. 홍삼 추출물은 유효성분을 포함하면서도 색도가 완화된 상태이므로, 화장품 또는 식품과 같은 제품 제조시 원료로 사용될 수 있다.The present invention relates to a method for preparing a red ginseng extract with reduced chromaticity, and by filtering the red ginseng extract through an ultrafiltration membrane having a predetermined molecular weight cutoff, a red ginseng extract having a reduced chromaticity and enhanced active ingredient can be obtained. Since red ginseng extract contains an active ingredient and its color is reduced, it can be used as a raw material in the manufacture of products such as cosmetics or food.
Description
본 발명은 색도가 감소된 홍삼 추출물의 제조 방법에 관한 것이다. The present invention relates to a method for producing a red ginseng extract with reduced color.
인삼은 오갈피나무과 인삼속(Panax)에 속하는 다년생 초본으로 한방에서 사용되는 한약재 중의 하나이다. 인삼에 열을 가해 홍삼을 제조하며, 홍삼에는 인삼에는 존재하지 않는 진세노사이드 성분이 생성된다. 진세노사이드는 지금까지 약 40여 종이 발견되고 있으며 중추신경계를 비롯하여 내분비계, 대사계 등에 광범위한 영향을 미쳐 신체 기능 조절, 즉 생리 기능 정상화에 탁월한 효과를 나타내는 것으로 확인되고 있다. 이들 진세노사이드는 서로 비슷한 작용을 하거나 또는 서로 반대되는 작용을 나타내기도 하는데, 특정 성분이 단독으로 또는 여러 종류가 상호작용을 통해서 다양한 효능을 발휘하는 것으로 알려져있다.Ginseng is a perennial herb belonging to the genus Panax, and is one of the herbal medicines used in oriental medicine. Red ginseng is produced by applying heat to ginseng, and ginsenosides that do not exist in ginseng are produced in red ginseng. About 40 species of ginsenosides have been discovered so far, and it has been confirmed to have an excellent effect on regulating body functions, that is, normalizing physiological functions, by exerting a wide range of effects on the central nervous system, endocrine system, and metabolic system. These ginsenosides have similar or opposite actions to each other, but it is known that specific ingredients exert various effects either alone or through interactions of several types.
아르기닌-프럭토스-글루코스(arginine-fructose-glucose, AFG)는 아미노당의 일종으로 위장관에서 당이 흡수되는 것을 억제하며, 지방의 흡수도 억제하므로 비만 및 당뇨병의 치료에 유효한 것으로 알려져 있다. 또한, 아미노당은 혈액 순환을 원활히 해주므로 고혈압, 동맥경화 및 뇌졸중 등 혈액순환기계 질병의 예방 및 치료에 효과적이다. 아미노당은 홍삼의 증숙(열처리) 과정에서 다량 생성되는 것으로 알려져 있으나, 시중의 홍삼 관련 제품, 특히 액상의 홍삼 추출액 제품들은 아미노당을 거의 포함하고 있지 않다. 따라서 아미노당이 고함량으로 포함되어 있는 홍삼 추출액을 제조하는 방법의 개발이 필요한 실정이다. Arginine-fructose-glucose (AFG) is a type of amino sugar and is known to be effective in the treatment of obesity and diabetes because it inhibits the absorption of sugar from the gastrointestinal tract and also suppresses the absorption of fat. In addition, since amino sugars facilitate blood circulation, they are effective in preventing and treating diseases of the blood circulation system such as high blood pressure, arteriosclerosis and stroke. Although it is known that a large amount of amino sugar is produced in the process of steaming (heat treatment) of red ginseng, commercial red ginseng-related products, especially liquid red ginseng extract products, contain almost no amino sugar. Therefore, it is necessary to develop a method for preparing a red ginseng extract containing a high content of amino sugar.
아미노산은 생체적합성 및 환경적합성에 우수한 물질로써, 화장품 원료로 광범위하게 사용되고 있다. 주요 아미노산들 중에서, 아르기닌은 분자 내에 구아니디닐기를 특징적인 작용기로 가져 피부 및 모발과의 흡착성이 매우 뛰어나다. 또한, 상피세포, 뇌신경세포, 중성구(neutrophil) 생성에도 반드시 필요하다. 현재까지는 아르기닌을 고함량으로 포함하는 추출 방법 연구에 초점을 맞추고 있고, 추출물로부터 아르기닌을 강화시키기 위한 가공 방법에 대해서는 연구가 미비하다.Amino acids are excellent in biocompatibility and environmental compatibility, and are widely used as raw materials for cosmetics. Among the major amino acids, arginine has a guanidine group as a characteristic functional group in its molecule, and has excellent adsorption properties to skin and hair. In addition, it is necessary for the production of epithelial cells, cranial nerve cells, and neutrophils. Up to now, the focus is on the research on the extraction method containing arginine in a high content, and the research on the processing method for enhancing arginine from the extract is insufficient.
천연물 추출물은 클로로필, 플라보노이드, 카로테노이드와 같은 강한 천연색소를 다량 함유하고 있기 때문에 이를 첨가하여 제품을 생산할 경우 기존 제품 색상의 변화를 초래하게 되는 문제점이 있어서, 천연물의 우수한 기능에도 불구하고 기능성 식품, 의약품 및 화장품 제조에 응용하는데 많은 제한이 있다. 이에 천연물 추출물에서 색소를 제거하기 위하여 복잡한 색소 정제 과정이 이용되고 있으나, 홍삼의 경우 제조수율, 경제적 이유 등으로 기존 공정이 뚜렷한 효과를 얻지 못하고 있다. 별도의 가공을 거치지 않은 홍삼 추출물 또한 짙은 갈색을 나타내며, 이 홍삼 추출물을 제품에 포함시키면, 제품의 색이 짙어져 기호도가 떨어진다. 특허문헌 1에는 원료의 색을 탈색하여 색도를 개선시키는 점이 개시되어 있다. Since natural product extracts contain a large amount of strong natural pigments such as chlorophyll, flavonoids, and carotenoids, there is a problem that the color of the existing product changes when the product is added to it. And there are many limitations in application to the manufacture of cosmetics. Accordingly, a complex pigment purification process is used to remove the pigment from the natural product extract, but in the case of red ginseng, the existing process does not obtain a distinct effect due to manufacturing yield and economic reasons. The red ginseng extract that has not been processed separately also exhibits a dark brown color, and if this red ginseng extract is included in the product, the color of the product becomes dark and the preference is deteriorated.
본 발명자들은 홍삼 추출물의 색도를 완화시키는 방법을 연구하였으며, 한외여과시 소정의 분획 분자량을 가지는 막을 이용함으로써, 홍삼 추출물의 색도가 감소되고, 진세노사이드, AFG, 아르기닌과 같은 유효성분이 강화되는 것을 확인하였다. The present inventors have studied a method of alleviating the chromaticity of red ginseng extract, and by using a membrane having a predetermined molecular weight fraction during ultrafiltration, the chromaticity of the red ginseng extract is reduced, and active ingredients such as ginsenoside, AFG, and arginine are strengthened. Confirmed.
본 발명은 색도가 개선되면서도, 유효성분이 강화된 홍삼 추출물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a red ginseng extract with improved colority and enhanced active ingredient.
본 발명의 목적을 달성하기 위한 하나의 양태로서, 본 발명의 일 측면은 홍삼 추출물을 한외여과하는 단계;를 포함하는 색도가 감소된 홍삼 추출물의 제조 방법을 제공한다.As an aspect for achieving the object of the present invention, an aspect of the present invention provides a method for preparing a red ginseng extract with reduced coloration comprising: ultrafiltration of a red ginseng extract.
또한, 본 발명의 다른 측면은 상기 제조 방법에 의해 제조된 색도가 감소된 홍삼 추출물을 제공한다.In addition, another aspect of the present invention provides a red ginseng extract with reduced chromaticity prepared by the above manufacturing method.
또한, 본 발명의 다른 측면은 상기 색도가 감소된 홍삼 추출물을 포함하는 화장료 조성물 또는 식품 조성물을 제공한다.In addition, another aspect of the present invention provides a cosmetic composition or a food composition comprising a red ginseng extract with reduced color.
본 발명의 색도가 감소된 홍삼 추출물은 종래의 홍삼 추출물에 비해서 저하된 색도를 나타내면서도, 유효성분을 포함하고 있으므로, 화장품 또는 식품에 원료로 포함시켜도 제품의 색상을 변질시키지 않고, 생리활성을 나타내는 효과가 있다.The red ginseng extract with reduced chromaticity of the present invention exhibits a reduced chromaticity compared to the conventional red ginseng extract, but contains an active ingredient. Therefore, even when included as a raw material in cosmetics or food, the red ginseng extract does not alter the color of the product and exhibits physiological activity. It works.
도 1은 홍삼 추출물을 한외여과시, 사용된 막의 분획 분자량에 따른 투과된 홍삼 추출물의 색도를 나타낸다.
도 2는 홍삼 추출물을 한외여과하여 얻어진 색도가 감소된 홍삼 추출물의 동결건조물 및 부형제를 추가하여 제조된 고형물을 나타낸다.1 shows the chromaticity of the permeated red ginseng extract according to the fractional molecular weight of the membrane used when ultrafiltration of the red ginseng extract.
FIG. 2 shows a lyophilized product of red ginseng extract with reduced chromaticity obtained by ultrafiltration of a red ginseng extract and a solid prepared by adding an excipient.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 홍삼 추출물을 한외여과하는 단계;를 포함하는 색도가 감소된 홍삼 추출물의 제조 방법을 제공한다.The present invention provides a method for producing a red ginseng extract with reduced chromaticity comprising: ultrafiltration of the red ginseng extract.
상기 홍삼은 인삼을 증숙하여 얻어진다.The red ginseng is obtained by steaming ginseng.
상기 인삼은 고려삼(Panax ginseng), 회기삼(P. quiquefolius), 전칠삼(P. notoginseng), 죽절삼(P. japonicus), 삼엽삼(P. trifolium), 히말라야삼(P. pseudoginseng), 베트남삼(P. vietnamensis), 또는 미국삼(P. quinquefolium) 등일 수 있다. 인삼은 일반적으로 가공 방법에 따라 백삼과 홍삼으로 구분되며, 백삼은 밭에서 채굴한 가공되지 아니한 인삼 즉, 수삼을 그대로 건조한 것을 지칭하며 홍삼은 수삼을 증숙하여 건조 가공한 것으로 제조 과정에서 사포닌 변형과 아미노산 변화 등 여러 화학적인 변화가 수반된다. 홍삼은 제조 과정에서 가해지는 열에 의해 인삼에 존재하지 않는 진세노사이드 성분이 생성되며, 홍삼 특유의 유효 성분은 암 예방 작용, 암세포 성장 억제 작용, 혈압 강하 작용, 뇌신경세포 보호, 학습 능력 개선 작용을 나타낸다.The ginseng is Korean ginseng ( Panax ginseng ), Hoegi ginseng (P. quiquefolius ), Jeonchil ginseng (P. notoginseng ), jukjeolsam (P. japonicus ), trifolium ginseng (P. trifolium ), Himalayan ginseng (P. pseudoginseng ), Vietnamese ginseng. ( P. vietnamensis ), or American ginseng (P. quinquefolium ), and the like. Ginseng is generally classified into white ginseng and red ginseng according to the processing method, and white ginseng refers to unprocessed ginseng mined in the field, that is, fresh ginseng as it is dried, and red ginseng is dried and processed by steaming fresh ginseng. Several chemical changes are involved, including amino acid changes. Red ginseng produces ginsenosides that do not exist in ginseng by the heat applied during the manufacturing process, and the unique active ingredient of red ginseng has cancer prevention action, cancer cell growth inhibition action, blood pressure lowering action, brain nerve cell protection, and learning ability improvement action. Show.
본 발명의 홍삼은 인삼의 잎, 어린 새싹, 줄기, 줄기 껍질, 뿌리, 뿌리 껍질, 종자, 열매, 미숙과, 완숙과, 과육, 과피, 꽃, 수술군(androecium), 암술군(gynoecium), 꽃받침, 수술, 꽃잎, 꽃받침 조각, 심피 및 이들의 조합으로 이루어진 군으로부터 선택되는 어느 하나를 9회 증숙하여 수득할 수 있다. 상기 수술군은 하나의 꽃에 있는 수술 전체를 나타내며, 상기 암술군은 하나의 꽃에 있는 암술 전체를 나타낸다. 상기 심피는 꽃의 암술을 만드는 구성 요소로 일반적으로 화엽이라고 총칭되는 잎의 변형 형태를 나타낸다. 상기 인삼은 뿌리일 수 있으나, 이에 한정되지 아니한다.The red ginseng of the present invention is a ginseng leaf, young shoot, stem, stem bark, root, root bark, seed, fruit, immature fruit, ripe fruit, flesh, pericarp, flower, stamen group (androecium), pistil group (gynoecium), Any one selected from the group consisting of calyxes, stamens, petals, calyx pieces, carpels, and combinations thereof can be obtained by steaming 9 times. The stamen group represents the entire stamen in one flower, and the pistil group represents the entire pistil in one flower. The carpel is a constituent element that makes a pistil of a flower, and represents a modified form of leaves, which is generally referred to as a flower leaf. The ginseng may be a root, but is not limited thereto.
본 발명에서 사용되는 용어 '추출물'은 원료로부터 임의의 방법으로 추출된 물질을 의미하며, 이렇게 추출된 추출액, 이로부터 얻을 수 있는 농축액, 상기 농축액의 건조물 및 분말을 제한 없이 모두 포함하는 의미로 사용된다.The term'extract' as used in the present invention refers to a material extracted from a raw material by any method, and is used to include all of the extracted extract, the concentrate obtainable therefrom, the dried product and powder of the concentrate without limitation. do.
상기 추출물은 원료 또는 이의 건조물로부터 추출하여 얻을 수 있으며, 상기 추출물의 원료는 재배한 것 또는 시판되는 것 등 제한 없이 사용할 수 있다.The extract may be obtained by extracting from a raw material or a dried product thereof, and the raw material of the extract may be used without limitation, such as cultivated or commercially available ones.
상기 추출물을 원료로부터 추출하여 수득할 때, 추출 방법으로는 용매 추출법, 초음파 추출법, 여과법 및 환류 추출법 등 종래 알려진 통상적인 추출 방법을 모두 사용할 수 있으며, 용매 추출법이나 환류 추출법을 이용함으로써 제조할 수 있다. 상기 추출 과정은 수회 반복할 수 있으며, 이후에 농축 또는 동결건조 등의 단계를 추가적으로 거칠 수 있다. 예를 들면, 수득한 추출물을 감압 농축하여 농축액을 얻고, 상기 농축액을 동결건조시킨 후 분쇄기를 이용하여 고농도의 추출 분말을 제조할 수 있다. 추출물은 추출물을 추가적으로 분획하여 얻은 분획물도 포함한다. When the extract is obtained by extracting from the raw material, all conventionally known extraction methods such as solvent extraction, ultrasonic extraction, filtration and reflux extraction may be used as the extraction method, and may be prepared by using a solvent extraction method or a reflux extraction method. . The extraction process may be repeated several times, and thereafter may be additionally subjected to steps such as concentration or freeze-drying. For example, the obtained extract is concentrated under reduced pressure to obtain a concentrate, and the concentrate is freeze-dried, and then a high-concentration extract powder can be prepared using a grinder. The extract also includes a fraction obtained by further fractionating the extract.
상기 추출물은 물, 유기용매 또는 이들의 혼합물을 추출용매로 하여 추출될 수 있다. 상기 유기용매는 알코올, 탄소수 1 내지 4의 저급 알코올, 헥산(n-헥산), 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄, 클로로포름, 에틸아세테이트, 벤젠 및 이들의 혼합용매로 이루어지는 군으로부터 선택되는 어느 하나일 수 있고, 추출물 제조시 용매는 물, 탄소수 1 내지 4의 저급 알코올, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 어느 하나일 수 있고, 추출물 제조시 용매는 물일 수 있다.The extract may be extracted using water, an organic solvent, or a mixture thereof as an extraction solvent. The organic solvent is alcohol, a lower alcohol having 1 to 4 carbon atoms, hexane (n-hexane), ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane, chloroform, ethyl acetate, benzene, and their It may be any one selected from the group consisting of a mixed solvent, and when preparing the extract, the solvent may be any one selected from the group consisting of water, a lower alcohol having 1 to 4 carbon atoms, and a mixed solvent thereof. Can be water.
상기 제조 방법은 한외여과 전에, 홍삼 추출물을 0.1 Brix 내지 30 Brix로 희석하는 단계;를 추가로 포함할 수 있다. 홍삼 추출물의 Brix 조정은 홍삼 추출물의 점도를 낮추어 한외여과가 가능한 점도로 제조하는 것이다. 홍삼 추출물은 0.1 Brix 내지 29 Brix, 1 Brix 내지 29 Brix, 2 Brix 내지 27 Brix, 2 Brix 내지 24 Brix, 2 Brix 내지 21 Brix, 2 Brix 내지 18 Brix, 3 Brix 내지 18 Brix일 수 있다. 홍삼 추출물의 Brix가 상기 범위일 경우 한외여과에 적용가능하고, 한외여과를 통해 얻어진 분획물이 색도가 감소되고, 유효성분이 강화될 수 있다. 홍삼 추출물의 Brix가 하한값 미만일 경우에는 한외여과에 적용가능하지만 여과해야 하는 액량이 많아져 공정상 수율이 낮아지므로 제조 효율이 감소되는 문제점이 있다. 홍삼 추출물의 Brix가 상한값을 초과할 경우에는 홍삼 추출물의 점도가 높아서 장시간 한외여과하여도 투과되는 분획물의 수율이 낮을 수 있다.The manufacturing method may further include a step of diluting the red ginseng extract to 0.1 Brix to 30 Brix before ultrafiltration. The Brix adjustment of the red ginseng extract is to lower the viscosity of the red ginseng extract to make it a viscosity capable of ultrafiltration. The red ginseng extract may be 0.1 Brix to 29 Brix, 1 Brix to 29 Brix, 2 Brix to 27 Brix, 2 Brix to 24 Brix, 2 Brix to 21 Brix, 2 Brix to 18 Brix, 3 Brix to 18 Brix. When the Brix of the red ginseng extract is within the above range, it is applicable to ultrafiltration, and the fraction obtained through ultrafiltration may have a reduced chromaticity, and an active ingredient may be enhanced. If the Brix of the red ginseng extract is less than the lower limit, it can be applied to ultrafiltration, but there is a problem in that the production efficiency decreases because the yield in the process is decreased due to the large amount of liquid to be filtered. If the Brix of the red ginseng extract exceeds the upper limit, the viscosity of the red ginseng extract may be high, and thus the yield of the fraction permeating through ultrafiltration for a long time may be low.
한외여과시 사용된 막의 분획 분자량이 10 kDa 이하, 5 kDa 이하, 3 kDa 이하, 1 kDa 이하, 600 Da 이하일 수 있다. 한외여과막의 분획 분자량이 10 kDa 이하인 경우, 이 막을 통과한 홍삼 추출물의 분획물은 여과 전의 홍삼 추출물에 비해서, 색도가 낮아 심미적 기호도가 높아진다. 한외여과막의 분획 분자량이 10 kDa를 초과하는 막을 이용하는 경우, 이 막을 통과한 홍삼 추출물의 분획물은 갈변 물질이 다량 포함되어 여과 전의 홍삼 추출물과 유사한 정도로 색도가 유지되어 화장품 또는 식품과 같은 제품에 첨가시 기호도가 감소될 수 있다. The fractional molecular weight of the membrane used during ultrafiltration may be 10 kDa or less, 5 kDa or less, 3 kDa or less, 1 kDa or less, 600 Da or less. When the fractional molecular weight of the ultrafiltration membrane is 10 kDa or less, the fraction of the red ginseng extract that has passed through the membrane has a lower chromaticity than that of the red ginseng extract before filtration, resulting in a higher aesthetic acceptability. When using a membrane with an ultrafiltration membrane having a molecular weight of more than 10 kDa, the fraction of the red ginseng extract that has passed through this membrane contains a large amount of browning substances and maintains color similar to that of the red ginseng extract before filtration, when added to products such as cosmetics or food. Acceptability can be reduced.
색도가 감소된 홍삼 추출물은 한외여과시 사용된 한외여과막을 통과한 것일 수 있다. 한외여과막을 통과한 분획물은 여과 전의 홍삼 추출물에 비해서, 색도가 감소되지만 한외여과막을 통과하지 못한 분획물은 여과 전의 홍삼 추출물과 유사한 정도로 색도가 유지되거나 증가한다.The red ginseng extract with reduced color may have passed through an ultrafiltration membrane used during ultrafiltration. Fractions that have passed through the ultrafiltration membrane have a reduced chromaticity compared to the red ginseng extract before filtration, but the fractions that have not passed through the ultrafiltration membrane maintain or increase their chromaticity to a similar degree to that of the red ginseng extract before filtration.
상기 제조 방법은 한외여과결과 제조된 분획물이 점조성을 가질 경우, 색도가 감소된 홍삼 추출물에 부형제를 첨가하고, 동결 건조하여 동결 건조물을 얻는 단계;를 추가로 포함할 수 있다. 상기 한외여과 결과 제조된 분획물은 한외여과시 분획 분자량이 5 kDa 이하인 막을 사용시 한외여과막을 통과한 것일 수 있다. 상기 부형제는 불활성 물질로, 직접적인 약효를 발휘하지 않으며 제품 섭취를 용이하게 하거나, 일정한 형태를 만들기 위하여 첨가하는 물질이며, 화장품, 식품 분야에서 사용되는 부형제라면 제한없이 본 발명에 적용할 수 있다. 분말제조시 사용되는 부형제로는 전분, 덱스트린, 말토덱스트린, 유당, 포도당, 맥아당, 젤라틴, 아라비아검, 사이클로덱스트린 등이 사용될 수 있고, 이들 중 덱스트린류(類)를 사용할 수 있다. 덱스트린류는 포도당과 맥아당을 제외한 전분의 가수분해 생성물을 나타내며 분해 정도를 나타내는 덱스트로스 당량(DE)에 따라 각기 다른 성질을 가지나 일반적으로 흡습성이 낮고 용해분산성이 우수하고 조직감 개선효과가 있다. The manufacturing method may further include the step of obtaining a freeze-dried product by adding an excipient to the red ginseng extract with reduced color and freeze-drying when the fraction prepared as a result of ultrafiltration has viscosity. The fraction produced as a result of the ultrafiltration may have passed through the ultrafiltration membrane when a membrane having a molecular weight cutoff of 5 kDa or less during ultrafiltration is used. The excipient is an inert substance, does not exert a direct medicinal effect, is a substance added to facilitate product intake or to form a certain form, and can be applied to the present invention without limitation as long as it is an excipient used in the fields of cosmetics and food. As excipients used in the manufacture of powder, starch, dextrin, maltodextrin, lactose, glucose, maltose, gelatin, gum arabic, cyclodextrin, and the like can be used, among which dextrins can be used. Dextrins represent the hydrolysis products of starch excluding glucose and maltose, and have different properties depending on the dextrose equivalent (DE) representing the degree of decomposition, but generally have low hygroscopicity, excellent dissolution and dispersibility, and improved texture.
상기 부형제의 함량은 색도가 감소된 홍삼 추출물 100중량부 기준으로 5중량부 내지 30중량부, 5중량부 내지 25중량부, 5중량부 내지 20중량부, 5중량부 내지 15중량부로 포함될 수 있다. 부형제가 하한값 미만으로 포함될 경우에는 색도가 감소된 홍삼 추출물이 분말화되지 않아 제품의 원료로 사용할 때에 취급시 편의성이 저하된다. 부형제가 상한값을 초과하여 포함될 경우에는 색도가 감소된 홍삼 추출물의 함량이 적어져 홍삼 추출물의 생리활성이 낮아질 수 있다.The content of the excipient may be included in 5 parts by weight to 30 parts by weight, 5 parts by weight to 25 parts by weight, 5 parts by weight to 20 parts by weight, 5 parts by weight to 15 parts by weight based on 100 parts by weight of the red ginseng extract with reduced color. . If the excipient is included below the lower limit, the red ginseng extract with reduced color is not powdered, and thus the convenience of handling when used as a raw material for a product decreases. When the excipient is included in excess of the upper limit, the content of the red ginseng extract with reduced color may decrease, so that the physiological activity of the red ginseng extract may be lowered.
본 발명은 상기 제조 방법에 의해서 제조된 색도가 감소된 홍삼 추출물을 제공한다. The present invention provides a red ginseng extract with reduced chromaticity prepared by the above manufacturing method.
색도가 감소된 홍삼 추출물이 1.27 Brix일 때, 색도는 440nm에서 흡광도 0.1500 이하, 0.0300 내지 0.1500, 0.0350 내지 0.1400, 0.0400 내지 0.1300, 0.0450 내지 0.1250, 0.0500 내지 0.1200일 수 있다. 홍삼 추출물의 색도가 상기 범위이면 화장품, 식품과 같은 제품에 원료로 첨가하여도 제품의 색에 영향을 주지 않으므로 기호도가 높아진다. 홍삼 추출물의 색도가 상한값을 초과하면 갈변 물질이 다량 포함되어 있기 때문에 화장품, 식품에 적용이 어렵다. When the red ginseng extract with reduced chromaticity is 1.27 Brix, the chromaticity may be 0.1500 or less, 0.0300 to 0.1500, 0.0350 to 0.1400, 0.0400 to 0.1300, 0.0450 to 0.1250, and 0.0500 to 0.1200 at 440 nm. If the color of the red ginseng extract is within the above range, even if it is added as a raw material to products such as cosmetics and food, it does not affect the color of the product, so the preference is increased. If the color of red ginseng extract exceeds the upper limit, it is difficult to apply to cosmetics and foods because it contains a large amount of browning substances.
상기 색도가 감소된 홍삼 추출물은 진세노사이드, AFG 및 아르기닌으로 이루어진 군으로부터 선택되는 어느 하나를 포함할 수 있다. The red ginseng extract with reduced chromaticity may include any one selected from the group consisting of ginsenoside, AFG, and arginine.
상기 진세노사이드는 진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1로 이루어진 군으로부터 선택되는 어느 하나를 포함할 수 있다. The ginsenoside may include any one selected from the group consisting of ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1.
진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계는 0.2 mg/g 이상, 0.3 mg/g 이상, 0.2 mg/g 내지 30 mg/g, 0.2 mg/g 내지 25 mg/g, 0.2 mg/g 내지 20 mg/g, 0.2 mg/g 내지 15 mg/g, 0.2 mg/g 내지 10 mg/g, 0.3 mg/g 내지 10 mg/g일 수 있다. The sum of the contents of ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1 is 0.2 mg/g or more, 0.3 mg/g or more, 0.2 mg/g to 30 mg/g , 0.2 mg/g to 25 mg/g, 0.2 mg/g to 20 mg/g, 0.2 mg/g to 15 mg/g, 0.2 mg/g to 10 mg/g, 0.3 mg/g to 10 mg/g Can be
진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계는 0.1 mg/g 이상, 0.1 mg/g 내지 12 mg/g, 0.1 mg/g 내지 10 mg/g, 0.1 mg/g 내지 8 mg/g, 0.1 mg/g 내지 6 mg/g, 0.1 mg/g 내지 5 mg/g일 수 있다. The sum of the contents of ginsenosides Rg1, Rb1 and Rg3 is 0.1 mg/g or more, 0.1 mg/g to 12 mg/g, 0.1 mg/g to 10 mg/g, 0.1 mg/g to 8 mg/g, 0.1 It may be from mg/g to 6 mg/g and from 0.1 mg/g to 5 mg/g.
진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계 100중량부 대비 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계가 40중량부 이상, 40중량부 내지 75중량부, 40중량부 내지 70중량부, 40중량부 내지 65중량부, 40중량부 내지 60중량부, 40중량부 내지 55중량부일 수 있다.Ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1 total 100 parts by weight of the total content of ginsenosides Rg1, Rb1 and Rg3 is 40 parts by weight or more, It may be 40 to 75 parts by weight, 40 to 70 parts by weight, 40 to 65 parts by weight, 40 to 60 parts by weight, 40 to 55 parts by weight.
상기 진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계; 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계; 또는 진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계 100중량부 대비 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계;가 상기 범위인 경우 진세노사이드에 의한 생리활성이 나타난다.The sum of the contents of the ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1; The sum of the contents of ginsenosides Rg1, Rb1 and Rg3; Or ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s, and the sum of the total content of the ginsenosides Rg1, Rb1 and Rg3 relative to 100 parts by weight of the total content of Rh1; In case, physiological activity by ginsenoside appears.
상기 AFG의 함량은 10 mg/g 내지 40 mg/g, 10 mg/g 내지 37 mg/g, 12 mg/g 내지 34 mg/g, 14 mg/g 내지 31 mg/g, 16 mg/g 내지 28 mg/g, 18 mg/g 내지 28 mg/g일 수 있다. AFG의 함량이 상기 범위이면 비만 및 당뇨병의 치료와 같은 AFG의 생리활성이 나타난다. The content of the AFG is 10 mg/g to 40 mg/g, 10 mg/g to 37 mg/g, 12 mg/g to 34 mg/g, 14 mg/g to 31 mg/g, 16 mg/g to It may be 28 mg/g, 18 mg/g to 28 mg/g. When the content of AFG is within the above range, the physiological activity of AFG, such as treatment of obesity and diabetes, appears.
상기 아르기닌의 함량은 5 mg/g 내지 40 mg/g, 5 mg/g 내지 38 mg/g, 7 mg/g 내지 36 mg/g, 9 mg/g 내지 34 mg/g, 11 mg/g 내지 32 mg/g일 수 있다. 아르기닌의 함량이 상기 범위이면 피부 및 모발에 흡착성을 나타내므로 색도가 감소된 홍삼 추출물을 원료로 포함하는 화장품의 기능성이 높아질 수 있다.The content of arginine is 5 mg/g to 40 mg/g, 5 mg/g to 38 mg/g, 7 mg/g to 36 mg/g, 9 mg/g to 34 mg/g, 11 mg/g to It may be 32 mg/g. If the content of arginine is within the above range, since it exhibits adsorption to skin and hair, the functionality of a cosmetic including a red ginseng extract having a reduced coloration as a raw material may be enhanced.
또한, 본 발명은 색도가 감소된 홍삼 추출물을 포함하는 화장료 조성물을 제공한다. In addition, the present invention provides a cosmetic composition comprising a red ginseng extract with reduced color.
상기 색도가 감소된 홍삼 추출물은 화장료 조성물 100 중량%에 대하여, 0.001 중량% 내지 60 중량%, 0.01 중량% 내지 50 중량%, 0.1 중량% 내지 45 중량%, 1 중량% 내지 40 중량%, 1 중량% 내지 20 중량%의 함량으로 포함될 수 있다. 상기 화장료 조성물 내의 색도가 감소된 홍삼 추출물의 함량이 0.001 중량% 미만일 경우에는 색도가 감소된 홍삼 추출물에 의한 생리 활성이 충분히 발현되지 않을 수 있고, 60 중량%를 초과할 경우에는 제형상의 문제점이 발생할 수 있다.The red ginseng extract with reduced color is 0.001% to 60% by weight, 0.01% to 50% by weight, 0.1% to 45% by weight, 1% to 40% by weight, 1% by weight, based on 100% by weight of the cosmetic composition It may be included in an amount of% to 20% by weight. If the content of the red ginseng extract with reduced color in the cosmetic composition is less than 0.001% by weight, the physiological activity by the red ginseng extract with reduced color may not be sufficiently expressed, and if it exceeds 60% by weight, there are problems in the formulation. Can occur.
본 발명의 화장료 조성물은 화장품 분야에서 통상적으로 사용되는 기제, 보조제 및 첨가제를 사용하여 액체 또는 고체 형태로 제조될 수 있다. 액체 또는 고체 형태의 화장품으로는, 예를 들면 화장수, 크림제, 로션제, 입욕제 등의 형태를 포함할 수 있고, 이에 한정되지는 않는다. 화장품 분야에서 통상적으로 사용되는 기제, 보조제 및 첨가제는 특별히 제한되지 않으며, 예를 들면 물, 알코올, 프로필렌글리콜, 스테아르산, 글리세롤, 세틸알코올, 유동 파라핀 등이 있다. The cosmetic composition of the present invention may be prepared in a liquid or solid form using bases, auxiliary agents, and additives commonly used in the cosmetic field. Cosmetics in liquid or solid form may include, for example, lotions, creams, lotions, and bath products, but are not limited thereto. Bases, auxiliary agents and additives commonly used in the cosmetic field are not particularly limited, and examples include water, alcohol, propylene glycol, stearic acid, glycerol, cetyl alcohol, liquid paraffin, and the like.
본 발명의 화장료 조성물은 색도가 감소된 홍삼 추출물뿐만 아니라, 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.The cosmetic composition of the present invention may include not only red ginseng extract with reduced color, but also components commonly used in cosmetic compositions, for example, conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, And it may include a carrier.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, It may be formulated as an oil, a powder foundation, an emulsion foundation, a wax foundation, and a spray, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray, or a powder.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide as carrier components Can be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸에테르와 같은 추진체를 포함할 수 있다. When the formulation of the cosmetic composition of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Propellants such as carbon, propane/butane or dimethyl ether may be included.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸아세테이트, 벤질알코올, 벤질벤조에이트, 프로필렌글리콜, 1,3-부틸렌글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르가 있다. When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene Glycol, 1,3-butylene glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다. When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester , Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, and the like may be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. When the formulation of the cosmetic composition of the present invention is a surfactant containing cleansing, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide ether Sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters may be used.
본 발명의 화장료 조성물은 단독 또는 중복 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한 본 발명에 따른 프로-콜라겐 합성량 증가 효과가 우수한 화장료 조성물은 통상적인 사용 방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.The cosmetic composition of the present invention may be used alone or in duplicate, or may be used in duplicate with other cosmetic compositions other than the present invention. In addition, the cosmetic composition having an excellent effect of increasing the amount of pro-collagen synthesis according to the present invention may be used according to a conventional method of use, and the number of times of use thereof may be varied according to a user's skin condition or taste.
본 발명의 화장료 조성물이 비누, 계면활성제 함유 클렌징 또는 계면활성제 비함유 클렌징 제형일 경우, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 구체적인 예로서, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클린징 제형은 클렌징 폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비함유 클렌징 제형은 클렌징 크림, 클렌징 로션, 클렌징 워터 및 클렌징 겔이며, 이에 한정되는 것은 아니다.When the cosmetic composition of the present invention is a soap, a cleansing formulation containing a surfactant, or a cleansing formulation containing no surfactant, it may be applied to the skin and then wiped off, removed, or washed off with water. As a specific example, the soap is liquid soap, powder soap, solid soap and oil soap, the surfactant-containing cleansing formulation is a cleansing foam, cleansing water, cleansing towel and cleansing pack, and the surfactant-free cleansing formulation is a cleansing cream , Cleansing lotion, cleansing water, and cleansing gel, but is not limited thereto.
또한, 본 발명은 색도가 감소된 홍삼 추출물을 포함하는 식품 조성물을 제공한다.In addition, the present invention provides a food composition comprising a red ginseng extract with reduced color.
본 발명의 식품 조성물은 분말, 과립, 정제, 캡슐, 시럽 또는 음료의 형태로 제공될 수 있으며, 상기 식품 조성물은 유효성분인 본 발명의 색도가 감소된 홍삼 추출물 이외에 다른 식품 또는 식품 첨가물과 함께 사용될 수 있다. 유효성분의 혼합량은 그의 사용 목적, 예를 들면 예방, 건강 또는 치료적 처치에 따라 적합하게 결정될 수 있다.The food composition of the present invention may be provided in the form of powder, granule, tablet, capsule, syrup or beverage, and the food composition may be used with other foods or food additives in addition to the red ginseng extract with reduced color of the present invention as an active ingredient. I can. The mixing amount of the active ingredient may be appropriately determined according to the purpose of its use, for example, prevention, health or therapeutic treatment.
색도가 감소된 홍삼 추출물은 식품 조성물에 0.001 중량% 내지 60 중량%, 예를 들면 0.01 중량% 내지 50 중량%, 0.1 중량% 내지 45 중량%, 1 중량% 내지 40 중량%, 1 중량% 내지 20 중량%의 함량으로 포함될 수 있다. 상기 식품 조성물 내에 색도가 감소된 홍삼 추출물의 함량이 0.001 중량% 미만일 경우에는 색도가 감소된 홍삼 추출물에 의한 생리활성이 충분히 발현되지 않을 수 있고, 60 중량%를 초과할 경우에는 제형상의 문제점이 발생할 수 있다.The red ginseng extract with reduced color is in the food composition from 0.001% to 60% by weight, for example, from 0.01% to 50% by weight, from 0.1% to 45% by weight, from 1% to 40% by weight, from 1% to 20% by weight. It may be included in an amount of weight %. If the content of the red ginseng extract with reduced chromaticity in the food composition is less than 0.001% by weight, the physiological activity of the red ginseng extract with reduced chromaticity may not be sufficiently expressed, and when it exceeds 60% by weight, the problem of formulation Can occur.
본 발명의 식품의 종류에는 특별한 제한이 없고, 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등을 들 수 있다.There is no particular limitation on the type of food of the present invention, and examples include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea. , Drinks, alcoholic beverages, and vitamin complexes.
이하, 본 발명을 제조예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Preparation Examples and Experimental Examples.
단, 하기 제조예, 실험예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 제조예 및 실험예에 의해 한정되는 것은 아니다.However, the following Preparation Examples and Experimental Examples are for illustrative purposes only, and the contents of the present invention are not limited by the following Preparation Examples and Experimental Examples.
제조예 1. 홍삼 물 추출물의 제조Preparation Example 1. Preparation of red ginseng water extract
건조된 홍삼(Panax ginseng) 500g에 6배의 증류수를 가해 85℃에서 10시간 추출하였다. 잔사에 대해서는 6배의 증류수를 가해 10시간 추출을 1~4회 추가로 실시하여 추출액을 여과 후 모두 혼합하였다. 회전감압농축기(BUCHI, R-220)를 이용하여 72 Brix가 되도록 농축하여 홍삼 농축액을 얻었다.To 500 g of dried red ginseng ( Panax ginseng ), 6 times of distilled water was added and extracted at 85°C for 10 hours. For the residue, 6 times of distilled water was added and extraction was further performed 1 to 4 times for 10 hours, and the extract was filtered and then all mixed. A red ginseng concentrate was obtained by concentrating to 72 Brix using a rotary vacuum concentrator (BUCHI, R-220).
제조예 2. 한외여과를 이용한 홍삼 농축액 여과Preparation Example 2. Filtration of red ginseng concentrate using ultrafiltration
한외여과시에는 홍삼 농축액을 16 Brix가 되도록 희석하여 사용하였다. 한외여과 막분리 장치((주)암포 모델 2319)를 이용하였다. 여과에는 분획 분자량이 각각 600 MW, 1000 MW, 3000 MW, 5000 MW, 10000 MW인 막을 사용하였다. 먼저, 분획 분자량이 10000 MW인 막부터 여과에 사용하였고, 10000 MW 적용시 투과된 액을 회수하고, 회수된 액을 분획 분자량이 5000 MW인 막을 이용하여 여과하였다. 이와 같이 분획 분자량이 큰 막부터 작은 막 순서로 순차적으로 여과를 수행하였다. 위 사용된 한외여과 막 각각에서 투과된 액들을 시료명으로 하였다. 예를 들면 시료명이 '10 kDa ~'인 것은 10000 MW인 막 사용시 투과되지 않은 액을 나타내고, '5~10 kDa'은 10000 MW인 막은 투과하고 5000 MW인 막은 투과하지 못한 액을 나타내며, '~ 5 kDa' 분획물은 분획 분자량이 5 kDa 또는 5 kDa 이하인 막을 이용하여 얻은 분획물들을 혼합한 액을 나타낸다. 얻어진 분획물을 동결건조 처리하고 제품 활용을 용이하게 하거나, 일정한 형태를 만들기 위하여 건조물을 분말화하였다.During ultrafiltration, the red ginseng concentrate was diluted to 16 Brix and used. An ultrafiltration membrane separation device (Ampo Model 2319 Co., Ltd.) was used. For filtration, membranes having cutoff molecular weights of 600 MW, 1000 MW, 3000 MW, 5000 MW, and 10000 MW, respectively, were used. First, a membrane having a molecular weight cutoff of 10000 MW was used for filtration, and when 10000 MW was applied, the permeated liquid was recovered, and the recovered liquid was filtered using a membrane having a molecular weight cutoff of 5000 MW. As described above, filtration was performed sequentially from the membrane having a large molecular weight cutoff to the small membrane. The liquids permeated through each of the ultrafiltration membranes used above were used as sample names. For example, a sample name of '10 kDa ~'indicates a liquid that was not permeated when using a 10000 MW membrane, and '5 to 10 kDa' indicates a liquid that was not permeated through a 10000 MW membrane and a 5000 MW membrane, and'~ The 5 kDa' fraction refers to a mixture of fractions obtained using a membrane having a molecular weight of 5 kDa or 5 kDa or less. The obtained fraction was lyophilized to facilitate product utilization, or the dried product was powdered to form a uniform shape.
실험예 1. 분획물의 색도 평가Experimental Example 1. Evaluation of chromaticity of fractions
홍삼 농축액을 화장품 또는 식품의 원료로 사용시에 색도가 높으면 기호도가 감소하기 때문에 한외여과하여 얻어진 분획물들이 색도가 개선되는지 확인하였다. 분획물을 동일 당도(1.27 Brix)로 희석한 후, 440nm에서 흡광도를 측정하여 희석된 분획물의 색도를 구하였다. 결과를 하기에 나타낸다. When the red ginseng concentrate was used as a raw material for cosmetics or food, it was confirmed that the chromaticity of the fractions obtained by ultrafiltration was improved because the acceptability decreased when the color was high. After diluting the fraction with the same sugar content (1.27 Brix), absorbance was measured at 440 nm to obtain the chromaticity of the diluted fraction. The results are shown below.
(분획물 혼합)~ 5 kDa
(Fraction mix)
5 kDa to 10 kDa
표 1 및 도 1에 나타낸 바와 같이, 분획 분자량이 10 kDa 이하인 막 이용시 투과된 홍삼 농축액은 색도가 0.11 이하였으며, 여과 전의 홍삼 농축액 또는 분획 분자량이 10 kDa인 막에서 투과되지 않은 홍삼 농축액에 비해서 색도가 현저히 감소하는 것으로 확인되었다.As shown in Table 1 and FIG. 1, when using a membrane with a molecular weight cutoff of 10 kDa or less, the permeated red ginseng concentrate had a chromaticity of 0.11 or less. Was found to be significantly reduced.
위 결과를 통해서 홍삼 농축액의 색도를 개선하기 위해서는 10 kDa 이하의 막을 이용해야 하는 것을 알 수 있다. 또한, 원료별로 포함된 성분이 상이하므로, 색도 조정을 목적으로 한외여과를 이용할 경우 원료에 따라 적합한 막을 사용해야 하는 것을 알 수 있다. From the above results, it can be seen that in order to improve the chromaticity of the red ginseng concentrate, a membrane of 10 kDa or less should be used. In addition, since the components included for each raw material are different, it can be seen that when ultrafiltration is used for the purpose of color adjustment, an appropriate film should be used depending on the raw material.
실험예 2. 분획물에 포함된 유효성분의 확인Experimental Example 2. Identification of the active ingredient contained in the fraction
실험예 1에서 화장품 또는 식품에 적용가능한 범위의 색도를 가지는 것으로 확인된 분획 분자량이 10 kDa인 막 적용시 투과된 분획물에 포함되어 있는 유효성분의 함량을 확인하였다. 유효성분의 함량은 72 Brix로 보정하였고, 하기에 결과를 나타낸다. 진세노사이드 3종의 합은 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합을 나타내고, 진세노사이드 11종의 합은 진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합을 나타낸다. 진세노사이드의 함량의 단위는 mg/g이고, AFG의 함량의 단위는 mg/g이며, 아르기닌의 함량의 단위는 mg/g이다. In Experimental Example 1, when a membrane having a molecular weight of 10 kDa was confirmed to have a chromaticity in a range applicable to cosmetics or food, the content of the active ingredient contained in the permeated fraction was confirmed. The content of the active ingredient was corrected to 72 Brix, and the results are shown below. The sum of the three ginsenosides represents the sum of the contents of ginsenosides Rg1, Rb1 and Rg3, and the sum of the 11 ginsenosides is ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, It represents the sum of the contents of Rg3r, Rg3s and Rh1. The unit of the content of ginsenoside is mg/g, the unit of the content of AFG is mg/g, and the unit of the content of arginine is mg/g.
1 kDa600 Da ~
1
3 kDa1 kDa ~
3
5 kDa3 kDa ~
5
분석 결과, 분획 분자량이 10 kDa인 막 적용시 투과된 분획물에는 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계가 3 mg/g 이상으로 기능식품공전의 함량 기준에 적합한 것을 확인하였다. 또한, 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계가 진세노사이드 11종의 함량의 합계 100중량% 대비 40중량% 이상으로 확인되었다. 또한, AFG, 아르기닌 함량이 높게 나타났다. 특히, AFG, 아르기닌은 여과하지 않은 홍삼 농축액 대비 함량이 높았다.As a result of the analysis, it was confirmed that the sum of the contents of ginsenosides Rg1, Rb1 and Rg3 was 3 mg/g or more in the fractions permeated when the membrane with a molecular weight cutoff of 10 kDa was applied, which was suitable for the content standard of the functional food code. In addition, the sum of the contents of ginsenosides Rg1, Rb1 and Rg3 was found to be 40% by weight or more compared to 100% by weight of the total content of 11 types of ginsenosides. In addition, the content of AFG and arginine was high. In particular, the content of AFG and arginine was higher than that of unfiltered red ginseng concentrate.
위 결과를 통해서, 홍삼 농축액을 분획 분자량이 10 kDa인 막으로 분리하여, 투과된 분획물이 색도가 낮으면서도 유효성분인 진세노사이드, AFG, 아르기닌을 포함하고 있으므로, 이들 유효성분을 필요로 하는 제품 제조시에 원료로 사용할 수 있는 것을 알 수 있다. Through the above results, the red ginseng concentrate was separated into a membrane with a molecular weight cutoff of 10 kDa, and the permeated fraction had low chromaticity and contained active ingredients such as ginsenoside, AFG, and arginine. It can be seen that it can be used as a raw material during manufacture.
실험예 3. 분획물의 동결건조물의 분말 제조Experimental Example 3. Preparation of lyophilized powder of fraction
제조예 2에서 얻어진 분획물을 동결건조 처리하고 제품 활용을 용이하게 하고, 일정한 형태로 만들기 위하여 분말화하였다. 점조성을 띄는 5 kDa 이하의 막으로 분획된 저분자 분획물('~5 kDa'분획물)은 덱스트린을 첨가 후 용해를 통해 균일하게 혼합하였으며, 재건조(동결건조) 과정을 거쳐 고형물로 제조한 후 분쇄하여 분말화하였다.The fraction obtained in Preparation Example 2 was lyophilized to facilitate product utilization and powdered to form a uniform shape. The low-molecular fraction ('~5 kDa' fraction) fractionated into a viscous membrane of 5 kDa or less was uniformly mixed through dissolution after addition of dextrin, and then re-dried (lyophilized) to form a solid and then pulverized. Powdered.
분말화 결과, 홍삼 농축액을 분획 분자량이 5 kDa인 막 또는 5 kDa 이하인 막으로 분리하여, 투과된 분획물인 '~ 5 kDa' 분획물의 경우 동결건조 직후에 고형 상태이고, 점도가 높아서 분말화되지 않았다. '~ 5 kDa' 분획물을 분말화하기 위하여 '~ 5 kDa' 분획물에 덱스트린을 9:1 중량비로 첨가 시 분말화되었다(도 2).As a result of powdering, the red ginseng concentrate was separated into a membrane having a molecular weight cutoff of 5 kDa or a membrane having a molecular weight of 5 kDa or less, and the'~ 5 kDa' fraction, which was the permeated fraction, was in a solid state immediately after lyophilization and was not powdered due to high viscosity. . In order to pulverize the'~ 5 kDa' fraction, dextrin was added to the'~ 5 kDa' fraction in a ratio of 9:1 by weight to powder (Fig. 2).
한외여과를 수행하지 않은 홍삼 농축액; 홍삼 농축액을 분획 분자량이 5 kDa인 막으로 분리시 투과되지 않고, 분획 분자량이 10 kDa인 막으로 분리시 투과된 분획물인 '5 kDa ~ 10 kDa' 분획물; 및 홍삼 농축액을 분획 분자량이 10 kDa인 막으로 분리시 투과되지 않은 '10 kDa ~' 분획물;은 동결건조 공정에서 100% 분말화되었다. '5 kDa ~ 10 kDa' 분획물을 제외하고, 홍삼 농축액 또는 '10 kDa ~' 분획물은 색도가 여전히 높았다(도 2).Red ginseng concentrate without ultrafiltration; When the red ginseng concentrate is separated by a membrane having a molecular weight cutoff of 5 kDa, it is not permeated, and a fraction of '5 kDa ~ 10 kDa', which is a fraction permeated when separated by a membrane having a molecular weight of 10 kDa; And the '10 kDa ~'fraction that was not permeated when the red ginseng concentrate was separated by a membrane having a molecular weight cutoff of 10 kDa; 100% was powdered in a freeze-drying process. Except for the '5 kDa ~ 10 kDa' fraction, the red ginseng concentrate or the '10 kDa ~'fraction still had high chromaticity (FIG. 2).
위 결과를 통해서, '~ 5 kDa' 분획물, '5 kDa ~ 10 kDa' 분획물의 경우, 즉 분획 분자량이 10 kDa 이하인 막을 이용하여 투과된 분획물은 색도가 낮고, 유효성분도 포함하고 있어서, 제품 원료로 사용가능성이 높은 것을 알 수 있고, '~ 5 kDa' 분획물의 경우에는 제품 가공시 편의성을 높이기 위해 분말화시에는 덱스트린의 사용이 필수적인 것을 알 수 있었다. From the above results, in the case of the'~ 5 kDa' fraction and the '5 kDa ~ 10 kDa' fraction, that is, the fraction permeated using a membrane with a molecular weight of less than 10 kDa has low chromaticity and contains active ingredients, it is used as a raw material for the product. It can be seen that the possibility of use is high, and in the case of the'~ 5 kDa' fraction, it was found that the use of dextrin is essential for powdering in order to increase the convenience during product processing.
제조예 3. 화장료 조성물의 제조Preparation Example 3. Preparation of cosmetic composition
3-1. 에센스의 제조3-1. Preparation of essence
색도가 감소된 홍삼 추출물을 이용하여 하기 표 3에 기재된 함량(중량부)에 따라 에센스를 각각 제조하였다.Essences were each prepared according to the content (parts by weight) shown in Table 3 below using the red ginseng extract with reduced color.
3-2. 유연화장수의 제조3-2. Manufacturing of flexible cosmetic water
색도가 감소된 홍삼 추출물을 유효성분으로 함유하는 유연화장수는 하기 표 4와 같이 제조하였다.Softening lotion containing red ginseng extract with reduced color as an active ingredient was prepared as shown in Table 4 below.
수소화 캐스터오일PEG-40
Hydrogenated Castor Oil
3-3. 영양 크림의 제조3-3. Preparation of nourishing cream
색도가 감소된 홍삼 추출물을 유효성분으로 함유하는 영양크림은 하기 표 5의 조성과 같이 제조하였다. A nutritional cream containing red ginseng extract with reduced color as an active ingredient was prepared as shown in Table 5 below.
3-4. 로션의 제조3-4. Lotion manufacture
색도가 감소된 홍삼 추출물을 유효성분으로 함유한 로션을 하기 표 6의 조성과 같이 제조하였다. A lotion containing red ginseng extract with reduced coloration as an active ingredient was prepared as shown in Table 6 below.
제조예 4. 식품의 제조Manufacture Example 4. Manufacture of food
4-1. 밀가루 식품의 제조4-1. Manufacture of flour food
본 발명의 색도가 감소된 홍삼 추출물 0.5 ~ 5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하였다.0.5 to 5.0 parts by weight of the red ginseng extract with reduced color of the present invention was added to flour, and bread, cakes, cookies, crackers, and noodles were prepared using this mixture.
4-2. 스프 및 육즙(gravies)의 제조4-2. Preparation of soups and gravies
본 발명의 색도가 감소된 홍삼 추출물 0.1 ~ 5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.0.1 to 5.0 parts by weight of the red ginseng extract with reduced color of the present invention was added to soups and juices to prepare health-promoting meat products, noodle soups, and juices.
4-3. 그라운드 비프(ground beef)의 제조4-3. Preparation of ground beef
본 발명의 색도가 감소된 홍삼 추출물 10 중량부를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.Ground beef for health promotion was prepared by adding 10 parts by weight of the red ginseng extract with reduced chromaticity of the present invention to ground beef.
4-4. 유제품(dairy products)의 제조4-4. Manufacture of dairy products
본 발명의 색도가 감소된 홍삼 추출물 5~10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.5 to 10 parts by weight of the red ginseng extract with reduced color of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
4-5. 선식의 제조4-5. Manufacturing of wiresik
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Brown rice, barley, glutinous rice, and adlay were gelatinized and dried by a known method, and then roasted, and then prepared into a powder having a particle size of 60 mesh with a grinder.
검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Black soybeans, black sesame seeds, and perilla seeds were also steamed and dried by a known method, and then roasted, and then prepared into powder having a particle size of 60 mesh by a grinder.
본 발명의 색도가 감소된 홍삼 추출물을 진공 농축기에서 감압농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.The red ginseng extract with reduced chromaticity of the present invention was concentrated under reduced pressure in a vacuum concentrator, sprayed and dried with a hot air dryer, and the resulting dried product was pulverized with a grinder to a particle size of 60 mesh to obtain a dry powder.
상기에서 제조한 곡물류, 종실류 및 본 발명의 색도가 감소된 홍삼 추출물을 다음의 비율로 배합하여 제조하였다.The grains, seeds and red ginseng extracts of the present invention with reduced chromaticity were mixed in the following ratio to prepare them.
곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부), 종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부), 본 발명의 색도가 감소된 홍삼 추출물(3 중량부), 영지(0.5 중량부), 지황(0.5 중량부)Cereals (30 parts by weight of brown rice, 15 parts by weight of barley, 20 parts by weight of barley), seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame), red ginseng extract with reduced color of the present invention (3 parts by weight) Part), Ganoderma lucidum (0.5 parts by weight), Rehmannia (0.5 parts by weight)
4-6. 건강음료의 제조4-6. Manufacturing of health drinks
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 색도가 감소된 홍삼 추출물 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.Subsidiary materials such as liquid fructose (0.5%), oligosaccharide (2%), sugar (2%), salt (0.5%), water (75%) and 5 g of red ginseng extract with reduced color of the present invention are homogeneously blended. After instant sterilization, it was prepared by packaging it in a small container such as a glass bottle or a plastic bottle.
4-7. 야채 주스의 제조4-7. Manufacture of vegetable juice
본 발명의 색도가 감소된 홍삼 추출물 5 g을 토마토 또는 당근 주스 1,000 ㎖에 가하여 야채 주스를 제조하였다.Vegetable juice was prepared by adding 5 g of red ginseng extract with reduced color of the present invention to 1,000 ml of tomato or carrot juice.
4-8. 과일 주스의 제조4-8. Manufacture of fruit juice
본 발명의 색도가 감소된 홍삼 추출물 1 g을 사과 또는 포도 주스 1,000 ㎖ 에 가하여 과일 주스를 제조하였다.A fruit juice was prepared by adding 1 g of the red ginseng extract with reduced color of the present invention to 1,000 ml of apple or grape juice.
Claims (19)
상기에서 한외여과된 분획물에 부형제를 첨가하는 단계; 및
상기 부형제가 첨가된 분획물을 분말화하는 단계;를 포함하는 색도가 감소된 홍삼 추출물의 제조 방법.Ultrafiltration of the red ginseng extract using a membrane having a molecular weight cutoff of 5 kDa or less;
Adding an excipient to the ultra-filtered fraction above; And
Powdering the fraction to which the excipient is added; a method of producing a red ginseng extract having reduced chromaticity.
홍삼 추출물 제조시 용매는 물, 탄소수 1 내지 4의 저급 알코올, 및 이들의 혼합 용매로 이루어지는 군으로부터 선택되는 어느 하나인 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 1,
When preparing the red ginseng extract, the solvent is any one selected from the group consisting of water, a lower alcohol having 1 to 4 carbon atoms, and a mixed solvent thereof.
상기 용매는 물인 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 2,
The solvent is water, a method of producing a red ginseng extract with reduced chromaticity.
한외여과 전에, 홍삼 추출물을 0.1 Brix 내지 30 Brix로 희석하는 단계;를 추가로 포함하는 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 1,
Before ultrafiltration, the step of diluting the red ginseng extract to 0.1 Brix to 30 Brix; Method for producing a red ginseng extract with reduced chromaticity further comprising.
상기 한외여과하는 단계는,
600 Da 이하의 분획 분자량을 갖는 막을 이용하여 한외여과된 분획물,
600 Da 초과 1 kDa 이하의 분획 분자량을 갖는 막을 이용하여 한외여과된 분획물,
1 kDa 초과 3 kDa 이하의 분획 분자량을 갖는 막을 이용하여 한외여과된 분획물, 및
3 kDa 초과 5 kDa 이하의 분획 분자량을 갖는 막을 이용하여 한외여과된 분획물을 혼합하는 것을 포함하는 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 1,
The ultrafiltration step,
Fractions ultra-filtered using a membrane having a molecular weight cutoff of 600 Da or less,
Ultrafiltered fraction using a membrane having a molecular weight cutoff of more than 600 Da and less than or equal to 1 kDa,
Ultrafiltered fraction using a membrane having a molecular weight cutoff of more than 1 kDa and less than or equal to 3 kDa, and
A method for producing a red ginseng extract with reduced chromaticity comprising mixing the ultra-filtered fraction using a membrane having a molecular weight cutoff of more than 3 kDa and less than or equal to 5 kDa.
색도가 감소된 홍삼 추출물은 한외여과시 사용된 한외여과막을 통과한 것인 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 1,
The red ginseng extract with reduced chromaticity is a method of producing a red ginseng extract with reduced chromaticity that has passed through an ultrafiltration membrane used during ultrafiltration.
상기 분말화하는 단계는 상기 부형제가 첨가된 분획물을 동결 건조하여 동결 건조물을 얻는 단계;를 포함하는 색도가 감소된 홍삼 추출물의 제조 방법.The method according to claim 1,
The pulverizing step is a step of obtaining a freeze-dried product by freeze-drying the fraction to which the excipient is added;
색도가 감소된 홍삼 추출물이 1.27 Brix일 때, 색도는 440nm에서 흡광도 0.1500 이하인 색도가 감소된 홍삼 추출물.The method of claim 9,
When the red ginseng extract with reduced chromaticity is 1.27 Brix, the red ginseng extract with reduced chromaticity having an absorbance of 0.1500 or less at 440 nm.
상기 색도가 감소된 홍삼 추출물은 진세노사이드, 아르기닌-프럭토스-글루코스(arginine-fructose-glucose, AFG) 및 아르기닌으로 이루어진 군으로부터 선택되는 어느 하나를 포함하는 색도가 감소된 홍삼 추출물.The method of claim 9,
The red ginseng extract with reduced chromaticity is a red ginseng extract with reduced chromaticity comprising any one selected from the group consisting of ginsenoside, arginine-fructose-glucose (arginine-fructose-glucose, AFG) and arginine.
상기 진세노사이드는 진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1로 이루어진 군으로부터 선택되는 어느 하나를 포함하는 색도가 감소된 홍삼 추출물.The method of claim 11,
The ginsenoside is a red ginseng extract with reduced chromaticity comprising any one selected from the group consisting of ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1.
진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계는 0.2 mg/g 이상인 색도가 감소된 홍삼 추출물.The method of claim 12,
Ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1 total content of 0.2 mg / g or more red ginseng extract with reduced color.
진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계는 0.1 mg/g 이상인 색도가 감소된 홍삼 추출물.The method of claim 12,
Ginsenosides Rg1, Rb1, and Rg3 total content is 0.1 mg / g or more red ginseng extract with reduced chromaticity.
진세노사이드 Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s 및 Rh1의 함량의 합계 100중량부 대비 진세노사이드 Rg1, Rb1 및 Rg3의 함량의 합계가 40중량부 이상인 색도가 감소된 홍삼 추출물.The method of claim 12,
Chromaticity in which the total content of ginsenosides Rg1, Rb1 and Rg3 is 40 parts by weight or more compared to 100 parts by weight of the total content of ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg2s, Rg3r, Rg3s and Rh1 Red ginseng extract with reduced.
상기 AFG의 함량은 10 mg/g 내지 40 mg/g인 색도가 감소된 홍삼 추출물.The method of claim 11,
The content of the AFG is 10 mg / g to 40 mg / g of red ginseng extract with reduced chromaticity.
상기 아르기닌의 함량은 5 mg/g 내지 40 mg/g인 색도가 감소된 홍삼 추출물.The method of claim 11,
The content of the arginine is 5 mg / g to 40 mg / g of red ginseng extract with reduced chromaticity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190082195A KR102252763B1 (en) | 2019-07-08 | 2019-07-08 | Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190082195A KR102252763B1 (en) | 2019-07-08 | 2019-07-08 | Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210006192A KR20210006192A (en) | 2021-01-18 |
KR102252763B1 true KR102252763B1 (en) | 2021-05-17 |
Family
ID=74236739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190082195A KR102252763B1 (en) | 2019-07-08 | 2019-07-08 | Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102252763B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230174364A (en) * | 2022-06-20 | 2023-12-28 | 주식회사 엑소스템텍 | High-purity ginseng exosome composition and its use in functional cosmetics |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101025903B1 (en) * | 2009-08-31 | 2011-03-30 | 주식회사 해림후코이단 | A discoloration method of fucoidan containing solution, discolorized fucoidan containing solution and cosmetic compositions for sensitive skins containing the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090022456A (en) * | 2007-08-30 | 2009-03-04 | 주식회사 케이티앤지 | Methods for preparing amino acid extract from red ginseng |
KR100951812B1 (en) | 2007-12-03 | 2010-04-07 | 전라북도 정읍시 | Decolorizing method of white lotus extract and cosmetic composition containing the same as an active ingredient |
KR101339671B1 (en) * | 2012-04-23 | 2013-12-11 | 재단법인 금산국제인삼약초연구소 | The Effective Isolation Method of Panaxadiol Saponin Fraction from Ginseng |
-
2019
- 2019-07-08 KR KR1020190082195A patent/KR102252763B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101025903B1 (en) * | 2009-08-31 | 2011-03-30 | 주식회사 해림후코이단 | A discoloration method of fucoidan containing solution, discolorized fucoidan containing solution and cosmetic compositions for sensitive skins containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20210006192A (en) | 2021-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190079202A (en) | Fermentation method of lactic acid bacteria using citrus fruit and its use | |
JP2017141199A (en) | Liver function improver | |
KR101288303B1 (en) | Method for preparing ginseng liquids containing high quantity of ginsenosides removed pigments and flavor components | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
KR101686196B1 (en) | A manufacturing method for red ginseng with enriched ginsenoside and a slice of red ginseng thereof | |
KR101292837B1 (en) | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient | |
KR20200053014A (en) | Anti-oxidant composition comprising the mixed extract of vegetable natural products having the effect on removal of swelling | |
JP2017141200A (en) | Absorption-promoting agent of shogaol and/or gingerol | |
KR101125225B1 (en) | A composition for skin wrinkle improvement comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR102252763B1 (en) | Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity | |
KR101474998B1 (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR102201312B1 (en) | Pharmaceutical Composition Comprising Extracts of Ginseng and Ginseng Berry for Preventing or Treating Muscle Disease | |
KR20110040375A (en) | Method for removing the pigment of centipede grass extract using irradiation | |
KR101525877B1 (en) | A composition for preventing wrinkle of skin and anti aging of skin | |
KR102352017B1 (en) | Method of Preparing Concentrate of Deer Antlers | |
KR102073016B1 (en) | Composition Comprising Red Ginseng Extract and Brassica oleracea Extract for Preventing or Treating Climacteric Syndrome | |
KR102072111B1 (en) | Antioxidant composition comprising defatted perilla extract as effective component and manufacturing method thereof | |
KR102508753B1 (en) | Method of Preparing Concentrate of Deer Antlers | |
KR102200906B1 (en) | Composition for preventing hair loss or promoting hair growth comprising a plant extract from which chlorophyll or pigment is removed and the manufacturing methods | |
KR102012170B1 (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR102384358B1 (en) | Antibacterial Composition Comprising Non-aqueous Extract Of Red Ginseng | |
KR101209369B1 (en) | Preparation method of fraction of Adenophora remoti flora extract and inner beauty food comprising the fraction | |
KR101907918B1 (en) | Manufacturing method of ginseng extract residue for preventing or improving skin wrinkle using acidic solution | |
KR20160144331A (en) | Food composition comprising ethanol extracts of medicinal herb residues, cosmetic composition, and the preparation method thereof | |
KR20230111465A (en) | Composion Comprising Fraction of Ginseng Flower Extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |